Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

被引：0
|
作者：
Rima Patel
Zhiqiang Li
Brittney S. Zimmerman
Marc Y. Fink
Jason D. Wells
Xiang Zhou
Kristin Ayers
Arielle Redfern
Scott Newman
Eric Schadt
William K. Oh
Rong Chen
Amy Tiersten
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology
[2] Sema4,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
Metastatic breast cancer; Obesity; Aromatase inhibitors; Hormone positive breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 319
页数：6
相关论文
共 50 条
  • [31] The role of aromatase inhibitors in the treatment of metastatic breast cancer
    Mouridsen, H
    Gershanovich, M
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 33 - 45
  • [32] The impact of body mass index (BMI) on the progression-free survival of CDK4/6 inhibitors in metastatic breast cancer patients (MBC)
    Artac, M.
    Caglayan, D.
    Kocak, M. Z.
    Geredeli, C.
    Tatli, A. M.
    Goksu, S. Sezgin
    Imaz, M. Karakurt Ery
    Araz, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S644 - S645
  • [33] Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone-receptor-positive postmenopausal breast cancer.
    Sendur, Mehmet Ali Nahit
    Aksoy, Sercan
    Silay, Kamile
    Akinci, Muhammed Bulent
    Ozdemir, Nuriye
    Yazici, Ozan
    Ozbek, Saliha
    Zengin, Nurullah
    Yalcin, Bulent
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Impact of Body Mass Index on Survival of Metastatic Renal Cancer
    Salgado Plonski, Jose Javier
    Fernandez-Pello, Sergio
    Ruger Jimenez, Laura
    Gonzalez Rodriguez, Ivan
    Alonso Calvar, Laura
    Rodriguez Villamil, Luis
    JOURNAL OF KIDNEY CANCER AND VHL, 2021, 8 (02): : 49 - 54
  • [35] Steroid aromatase inhibitors in metastatic breast cancer after disease progression to nonsteroid inhibitors-efficacy?
    Pesic, J.
    Donat, D.
    Tesanovic, S.
    Trifunovic, J.
    Pesic, T.
    Donat, D. D.
    Muzikravic, L. J.
    EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 178
  • [36] The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: A prospective study
    Alarfi H.
    Salamoon M.
    Kadri M.
    Alammar M.
    Haykal M.A.
    Alseoudi A.
    Youssef L.A.
    BMC Research Notes, 10 (1)
  • [37] Impact of body-mass index on setup displacement in patients with breast cancer
    Tsai, Y. C.
    Chen, C. Y.
    Tsai, J. T.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S638 - S638
  • [38] Effect of Body Mass Index (BMI) on the Effectivity of Aromatase Inhibitors in postmenopausal Breast Cancer Patients with Consideration of the Serum Hormone Level - a prospective Study
    Pfeiler, G.
    Maroske, M.
    Ban, G.
    Exner, R.
    Fitzal, F.
    Fink-Retter, A.
    Seifert, M.
    Panhofer, T.
    Singer, C.
    Gnant, M.
    Dubsky, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
  • [39] The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors
    Artac, Mehmet
    Bozcuk, Hakan
    Afacan, Berna
    Ozdogan, Mustafa
    Samur, Mustafa
    BREAST, 2008, 17 (04): : 418 - 422
  • [40] Efficacy and safety of aromatase inhibitors in early breast cancer
    Ozair, Sundus
    Iqbal, Shabana
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (05) : 547 - 558
12345